Jun 30, 2008
FDA approves generic form of J&J's Risperdal
NEW YORK -- Johnson & Johnson's blockbuster anti-psychotic drug Risperdal will face generic competition, as Teva Pharmaceutical Industries Ltd.
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Alamogordo police logs | 5 hr | Chester | 23 |
| Warren seniors' efforts 'blanket' children with... | 8 hr | Gayle Miller | 1 |
| Us Fda probing deaths in German study involving... | Oct 3 | gdpawel | 1 |
| FDA staff sees possible J&J psoriasis drug risks | Jul '08 | Barbara | 1 |
| FDA panel gives mixed review of J&J antibiotic | Jul '08 | bbednarz | 1 |
| Alamogordo Police Logs | Jul '08 | Not a Christian | 9 |
| Harvard University Psych Drug Pusher Dr. Bieder... | Jun '08 | What | 2 |
